APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sutureless Aortic Biological Valve

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sutureless Aortic Biological Valve Market Outlook and Growth Opportunities 2026

25 December 2025190 pages

Choose your research edition.

Industry ResearchSutureless Aortic Biological Valve Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Sutureless Aortic Biological Valve Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Sutureless Aortic Biological Valve Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sutureless Aortic Biological Valve Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Sutureless Aortic Biological Valve Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Sutureless Aortic Biological Valve market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sutureless Aortic Biological Valve is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sutureless Aortic Biological Valve is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sutureless Aortic Biological Valve is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sutureless Aortic Biological Valve market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sutureless Aortic Biological Valve market include Edwards Lifesciences, Braile Biomedica, Corcym, LivaNova, Medtronic, Colibri Heart Valve and Jiecheng Medical Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sutureless Aortic Biological Valve market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sutureless Aortic Biological Valve and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sutureless Aortic Biological Valve sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sutureless Aortic Biological Valve market size, projected growth trends, production technologies, key applications, and end-use industries.

Sutureless Aortic Biological Valve Segment by Company

Edwards Lifesciences

Braile Biomedica

Corcym

LivaNova

Medtronic

Colibri Heart Valve

Jiecheng Medical Technology

Sutureless Aortic Biological Valve Segment by Type

Porcine Tissue

Bovine Tissue

Sutureless Aortic Biological Valve Segment by Application

Public Hospital

Private Hospital

Sutureless Aortic Biological Valve Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sutureless Aortic Biological Valve status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sutureless Aortic Biological Valve market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sutureless Aortic Biological Valve significant trends, drivers, influence factors in global and regions.

6. To analyze Sutureless Aortic Biological Valve competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sutureless Aortic Biological Valve market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sutureless Aortic Biological Valve and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sutureless Aortic Biological Valve.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sutureless Aortic Biological Valve market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sutureless Aortic Biological Valve industry.

Chapter 3: Detailed analysis of Sutureless Aortic Biological Valve manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sutureless Aortic Biological Valve in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sutureless Aortic Biological Valve in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sutureless Aortic Biological Valve Industry Trends Table 2. Sutureless Aortic Biological Valve Industry Drivers Table 3. Sutureless Aortic Biological Valve Industry Opportunities and Challenges Table 4. Sutureless Aortic Biological Valve Industry Restraints Table 5. Global Sutureless Aortic Biological Valve Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sutureless Aortic Biological Valve Revenue Share by Company (2021-2026) Table 7. Global Sutureless Aortic Biological Valve Sales Volume by Company (Units) & (2021-2026) Table 8. Global Sutureless Aortic Biological Valve Sales Volume Share by Company (2021-2026) Table 9. Global Sutureless Aortic Biological Valve Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Sutureless Aortic Biological Valve Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sutureless Aortic Biological Valve Key Company Manufacturing Base & Headquarters Table 12. Global Sutureless Aortic Biological Valve Company, Product Type & Application Table 13. Global Sutureless Aortic Biological Valve Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sutureless Aortic Biological Valve by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Porcine Tissue Table 18. Significant Companies of Bovine Tissue Table 19. Global Sutureless Aortic Biological Valve Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Sutureless Aortic Biological Valve Sales Volume by Type (2021-2026) & (Units) Table 21. Global Sutureless Aortic Biological Valve Sales Volume by Type (2027-2032) & (Units) Table 22. Global Sutureless Aortic Biological Valve Sales Volume Share by Type (2021-2026) Table 23. Global Sutureless Aortic Biological Valve Sales Volume Share by Type (2027-2032) Table 24. Global Sutureless Aortic Biological Valve Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Sutureless Aortic Biological Valve Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Sutureless Aortic Biological Valve Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Sutureless Aortic Biological Valve Sales Value Share by Type (2021-2026) Table 28. Global Sutureless Aortic Biological Valve Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Public Hospital Table 30. Significant Companies of Private Hospital Table 31. Global Sutureless Aortic Biological Valve Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 32. Global Sutureless Aortic Biological Valve Sales Volume by Application (2021-2026) & (Units) Table 33. Global Sutureless Aortic Biological Valve Sales Volume by Application (2027-2032) & (Units) Table 34. Global Sutureless Aortic Biological Valve Sales Volume Share by Application (2021-2026) Table 35. Global Sutureless Aortic Biological Valve Sales Volume Share by Application (2027-2032) Table 36. Global Sutureless Aortic Biological Valve Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Sutureless Aortic Biological Valve Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Sutureless Aortic Biological Valve Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Sutureless Aortic Biological Valve Sales Value Share by Application (2021-2026) Table 40. Global Sutureless Aortic Biological Valve Sales Value Share by Application (2027-2032) Table 41. Global Sutureless Aortic Biological Valve Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 42. Global Sutureless Aortic Biological Valve Sales by Region (2021-2026) & (Units) Table 43. Global Sutureless Aortic Biological Valve Sales Market Share by Region (2021-2026) Table 44. Global Sutureless Aortic Biological Valve Sales by Region (2027-2032) & (Units) Table 45. Global Sutureless Aortic Biological Valve Sales Market Share by Region (2027-2032) Table 46. Global Sutureless Aortic Biological Valve Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Sutureless Aortic Biological Valve Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Sutureless Aortic Biological Valve Sales Value Share by Region (2021-2026) Table 49. Global Sutureless Aortic Biological Valve Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Sutureless Aortic Biological Valve Sales Value Share by Region (2027-2032) Table 51. Global Sutureless Aortic Biological Valve Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Sutureless Aortic Biological Valve Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Sutureless Aortic Biological Valve Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 54. Global Sutureless Aortic Biological Valve Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Sutureless Aortic Biological Valve Sales by Country (2021-2026) & (Units) Table 56. Global Sutureless Aortic Biological Valve Sales Market Share by Country (2021-2026) Table 57. Global Sutureless Aortic Biological Valve Sales by Country (2027-2032) & (Units) Table 58. Global Sutureless Aortic Biological Valve Sales Market Share by Country (2027-2032) Table 59. Global Sutureless Aortic Biological Valve Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Sutureless Aortic Biological Valve Sales Value Market Share by Country (2021-2026) Table 61. Global Sutureless Aortic Biological Valve Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Sutureless Aortic Biological Valve Sales Value Market Share by Country (2027-2032) Table 63. Edwards Lifesciences Company Information Table 64. Edwards Lifesciences Business Overview Table 65. Edwards Lifesciences Sutureless Aortic Biological Valve Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Edwards Lifesciences Sutureless Aortic Biological Valve Product Portfolio Table 67. Edwards Lifesciences Recent Development Table 68. Braile Biomedica Company Information Table 69. Braile Biomedica Business Overview Table 70. Braile Biomedica Sutureless Aortic Biological Valve Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Braile Biomedica Sutureless Aortic Biological Valve Product Portfolio Table 72. Braile Biomedica Recent Development Table 73. Corcym Company Information Table 74. Corcym Business Overview Table 75. Corcym Sutureless Aortic Biological Valve Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Corcym Sutureless Aortic Biological Valve Product Portfolio Table 77. Corcym Recent Development Table 78. LivaNova Company Information Table 79. LivaNova Business Overview Table 80. LivaNova Sutureless Aortic Biological Valve Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. LivaNova Sutureless Aortic Biological Valve Product Portfolio Table 82. LivaNova Recent Development Table 83. Medtronic Company Information Table 84. Medtronic Business Overview Table 85. Medtronic Sutureless Aortic Biological Valve Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Medtronic Sutureless Aortic Biological Valve Product Portfolio Table 87. Medtronic Recent Development Table 88. Colibri Heart Valve Company Information Table 89. Colibri Heart Valve Business Overview Table 90. Colibri Heart Valve Sutureless Aortic Biological Valve Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Colibri Heart Valve Sutureless Aortic Biological Valve Product Portfolio Table 92. Colibri Heart Valve Recent Development Table 93. Jiecheng Medical Technology Company Information Table 94. Jiecheng Medical Technology Business Overview Table 95. Jiecheng Medical Technology Sutureless Aortic Biological Valve Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Jiecheng Medical Technology Sutureless Aortic Biological Valve Product Portfolio Table 97. Jiecheng Medical Technology Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Sutureless Aortic Biological Valve Distributors List Table 101. Sutureless Aortic Biological Valve Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Sutureless Aortic Biological Valve Product Image Figure 2. Global Sutureless Aortic Biological Valve Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sutureless Aortic Biological Valve Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sutureless Aortic Biological Valve Sales (2021-2032) & (Units) Figure 5. Global Sutureless Aortic Biological Valve Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Sutureless Aortic Biological Valve Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Porcine Tissue Image Figure 10. Bovine Tissue Image Figure 11. Global Sutureless Aortic Biological Valve Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global Sutureless Aortic Biological Valve Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Sutureless Aortic Biological Valve Sales Volume Share by Type (2021-2032) Figure 14. Global Sutureless Aortic Biological Valve Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Sutureless Aortic Biological Valve Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Sutureless Aortic Biological Valve Sales Value Share by Type (2021-2032) Figure 17. Public Hospital Image Figure 18. Private Hospital Image Figure 19. Global Sutureless Aortic Biological Valve Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 20. Global Sutureless Aortic Biological Valve Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Sutureless Aortic Biological Valve Sales Volume Share by Application (2021-2032) Figure 22. Global Sutureless Aortic Biological Valve Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Sutureless Aortic Biological Valve Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Sutureless Aortic Biological Valve Sales Value Share by Application (2021-2032) Figure 25. Global Sutureless Aortic Biological Valve Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 26. Global Sutureless Aortic Biological Valve Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Sutureless Aortic Biological Valve Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Sutureless Aortic Biological Valve Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Sutureless Aortic Biological Valve Sales Value (2021-2032) & (US$ Million) Figure 30. North America Sutureless Aortic Biological Valve Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Sutureless Aortic Biological Valve Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Sutureless Aortic Biological Valve Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Sutureless Aortic Biological Valve Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Sutureless Aortic Biological Valve Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Sutureless Aortic Biological Valve Sales Value (2021-2032) & (US$ Million) Figure 36. South America Sutureless Aortic Biological Valve Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Sutureless Aortic Biological Valve Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Sutureless Aortic Biological Valve Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Sutureless Aortic Biological Valve Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Sutureless Aortic Biological Valve Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Porcine Tissue
  • Bovine Tissue
Applications
  • Public Hospital
  • Private Hospital
Companies covered
  • Edwards Lifesciences
  • Braile Biomedica
  • Corcym
  • LivaNova
  • Medtronic
  • Colibri Heart Valve
  • Jiecheng Medical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sutureless Aortic Biological Valve Sales Value (2021-2032)
  4. 1.2.2 Global Sutureless Aortic Biological Valve Sales Volume (2021-2032)
  5. 1.2.3 Global Sutureless Aortic Biological Valve Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sutureless Aortic Biological Valve Market Dynamics
  1. 2.1 Sutureless Aortic Biological Valve Industry Trends
  2. 2.2 Sutureless Aortic Biological Valve Industry Drivers
  3. 2.3 Sutureless Aortic Biological Valve Industry Opportunities and Challenges
  4. 2.4 Sutureless Aortic Biological Valve Industry Restraints
3 Sutureless Aortic Biological Valve Market by Company
  1. 3.1 Global Sutureless Aortic Biological Valve Company Revenue Ranking in 2025
  2. 3.2 Global Sutureless Aortic Biological Valve Revenue by Company (2021-2026)
  3. 3.3 Global Sutureless Aortic Biological Valve Sales Volume by Company (2021-2026)
  4. 3.4 Global Sutureless Aortic Biological Valve Average Price by Company (2021-2026)
  5. 3.5 Global Sutureless Aortic Biological Valve Company Ranking (2024-2026)
  6. 3.6 Global Sutureless Aortic Biological Valve Company Manufacturing Base and Headquarters
  7. 3.7 Global Sutureless Aortic Biological Valve Company Product Type and Application
  8. 3.8 Global Sutureless Aortic Biological Valve Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sutureless Aortic Biological Valve Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sutureless Aortic Biological Valve Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sutureless Aortic Biological Valve Market by Type
  1. 4.1 Sutureless Aortic Biological Valve Type Introduction
  2. 4.1.1 Porcine Tissue
  3. 4.1.2 Bovine Tissue
  4. 4.2 Global Sutureless Aortic Biological Valve Sales Volume by Type
  5. 4.2.1 Global Sutureless Aortic Biological Valve Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Sutureless Aortic Biological Valve Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Sutureless Aortic Biological Valve Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Sutureless Aortic Biological Valve Sales Value by Type
  9. 4.3.1 Global Sutureless Aortic Biological Valve Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Sutureless Aortic Biological Valve Sales Value by Type (2021-2032)
  11. 4.3.3 Global Sutureless Aortic Biological Valve Sales Value Share by Type (2021-2032)
5 Sutureless Aortic Biological Valve Market by Application
  1. 5.1 Sutureless Aortic Biological Valve Application Introduction
  2. 5.1.1 Public Hospital
  3. 5.1.2 Private Hospital
  4. 5.2 Global Sutureless Aortic Biological Valve Sales Volume by Application
  5. 5.2.1 Global Sutureless Aortic Biological Valve Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Sutureless Aortic Biological Valve Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Sutureless Aortic Biological Valve Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Sutureless Aortic Biological Valve Sales Value by Application
  9. 5.3.1 Global Sutureless Aortic Biological Valve Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Sutureless Aortic Biological Valve Sales Value by Application (2021-2032)
  11. 5.3.3 Global Sutureless Aortic Biological Valve Sales Value Share by Application (2021-2032)
6 Sutureless Aortic Biological Valve Regional Sales and Value Analysis
  1. 6.1 Global Sutureless Aortic Biological Valve Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sutureless Aortic Biological Valve Sales by Region (2021-2032)
  3. 6.2.1 Global Sutureless Aortic Biological Valve Sales by Region: 2021-2026
  4. 6.2.2 Global Sutureless Aortic Biological Valve Sales by Region (2027-2032)
  5. 6.3 Global Sutureless Aortic Biological Valve Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sutureless Aortic Biological Valve Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sutureless Aortic Biological Valve Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sutureless Aortic Biological Valve Sales Value by Region (2027-2032)
  9. 6.5 Global Sutureless Aortic Biological Valve Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sutureless Aortic Biological Valve Sales Value (2021-2032)
  12. 6.6.2 North America Sutureless Aortic Biological Valve Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sutureless Aortic Biological Valve Sales Value (2021-2032)
  15. 6.7.2 Europe Sutureless Aortic Biological Valve Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sutureless Aortic Biological Valve Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sutureless Aortic Biological Valve Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sutureless Aortic Biological Valve Sales Value (2021-2032)
  21. 6.9.2 South America Sutureless Aortic Biological Valve Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sutureless Aortic Biological Valve Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sutureless Aortic Biological Valve Sales Value Share by Country, 2025 VS 2032
7 Sutureless Aortic Biological Valve Country-level Sales and Value Analysis
  1. 7.1 Global Sutureless Aortic Biological Valve Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sutureless Aortic Biological Valve Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sutureless Aortic Biological Valve Sales by Country (2021-2032)
  4. 7.3.1 Global Sutureless Aortic Biological Valve Sales by Country (2021-2026)
  5. 7.3.2 Global Sutureless Aortic Biological Valve Sales by Country (2027-2032)
  6. 7.4 Global Sutureless Aortic Biological Valve Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sutureless Aortic Biological Valve Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sutureless Aortic Biological Valve Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sutureless Aortic Biological Valve Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sutureless Aortic Biological Valve Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sutureless Aortic Biological Valve Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Edwards Lifesciences
  2. 8.1.1 Edwards Lifesciences Company Information
  3. 8.1.2 Edwards Lifesciences Business Overview
  4. 8.1.3 Edwards Lifesciences Sutureless Aortic Biological Valve Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Edwards Lifesciences Sutureless Aortic Biological Valve Product Portfolio
  6. 8.1.5 Edwards Lifesciences Recent Developments
  7. 8.2 Braile Biomedica
  8. 8.2.1 Braile Biomedica Company Information
  9. 8.2.2 Braile Biomedica Business Overview
  10. 8.2.3 Braile Biomedica Sutureless Aortic Biological Valve Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Braile Biomedica Sutureless Aortic Biological Valve Product Portfolio
  12. 8.2.5 Braile Biomedica Recent Developments
  13. 8.3 Corcym
  14. 8.3.1 Corcym Company Information
  15. 8.3.2 Corcym Business Overview
  16. 8.3.3 Corcym Sutureless Aortic Biological Valve Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Corcym Sutureless Aortic Biological Valve Product Portfolio
  18. 8.3.5 Corcym Recent Developments
  19. 8.4 LivaNova
  20. 8.4.1 LivaNova Company Information
  21. 8.4.2 LivaNova Business Overview
  22. 8.4.3 LivaNova Sutureless Aortic Biological Valve Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 LivaNova Sutureless Aortic Biological Valve Product Portfolio
  24. 8.4.5 LivaNova Recent Developments
  25. 8.5 Medtronic
  26. 8.5.1 Medtronic Company Information
  27. 8.5.2 Medtronic Business Overview
  28. 8.5.3 Medtronic Sutureless Aortic Biological Valve Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Medtronic Sutureless Aortic Biological Valve Product Portfolio
  30. 8.5.5 Medtronic Recent Developments
  31. 8.6 Colibri Heart Valve
  32. 8.6.1 Colibri Heart Valve Company Information
  33. 8.6.2 Colibri Heart Valve Business Overview
  34. 8.6.3 Colibri Heart Valve Sutureless Aortic Biological Valve Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Colibri Heart Valve Sutureless Aortic Biological Valve Product Portfolio
  36. 8.6.5 Colibri Heart Valve Recent Developments
  37. 8.7 Jiecheng Medical Technology
  38. 8.7.1 Jiecheng Medical Technology Company Information
  39. 8.7.2 Jiecheng Medical Technology Business Overview
  40. 8.7.3 Jiecheng Medical Technology Sutureless Aortic Biological Valve Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jiecheng Medical Technology Sutureless Aortic Biological Valve Product Portfolio
  42. 8.7.5 Jiecheng Medical Technology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sutureless Aortic Biological Valve Value Chain Analysis
  2. 9.1.1 Sutureless Aortic Biological Valve Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sutureless Aortic Biological Valve Sales Mode & Process
  6. 9.2 Sutureless Aortic Biological Valve Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sutureless Aortic Biological Valve Distributors
  9. 9.2.3 Sutureless Aortic Biological Valve Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst